Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Those who have had a gastric bypass or other bariatric surgery [*]
Table of contents Introduction to BPC-157 and GHK-Cu Preclinical Models Used in Research BPC-157 and GHK-Cu in Wound Healing Synergistic Effects of BPC-157 and GHK-Cu Molecular Mechanisms of Action Safety and Toxicology in Preclinical Studies Potential Therapeutic Applications Conclusion FAQs CTA Introduction to BPC-157 and GHK-Cu BPC-157 and GHK-Cu are peptides studied for their potential in tissue repair and recovery
Additional preclinical work published in Cell Chemical Biology evaluated NNMT inhibition in similar diet-induced obesity models and confirmed the pattern: significant reductions in body weight gain, adipose tissue expansion, and circulating triglycerides compared to untreated controls
Dosage ranges reported in literature: Conservative start: 200 to 250 mcg daily, split into two doses of 100 to 125 mcg administered 12 hours apart Standard protocol: 300 to 400 mcg daily, considered the optimal range for most healing applications based on clinical observations Acute injury protocol: 400 to 500 mcg daily, split into two to three doses throughout the day Weight-based considerations: Under 150 pounds: 200 to 300 mcg daily 150 to 200 pounds: 300 to 400 mcg daily Over 200 pounds: 400 to 500 mcg daily Cycle length typically runs four to eight weeks, with some practitioners suggesting six to twelve weeks followed by a four to eight week break
Biochemical Journal , 467(2), 289301
We can arrange for a medical provider to reach out if needed
US$ 25.53
US$ 29.74
US$ 27.18
US$ 21.46
US$ 25.55
US$ 20.06
US$ 29.28
US$ 24.44
US$ 23.63
US$ 27.08
